Nxera Pharma Co Ltd (SOLTF)
8.052
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Nxera Pharma Market Cap: 723.88M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 14, 2024 | 723.88M |
| November 13, 2024 | 723.88M |
| November 12, 2024 | 723.88M |
| November 11, 2024 | 723.88M |
| November 08, 2024 | 685.95M |
| November 07, 2024 | 696.73M |
| November 06, 2024 | 696.73M |
| November 05, 2024 | 696.73M |
| November 04, 2024 | 696.73M |
| November 01, 2024 | 651.78M |
| October 31, 2024 | 651.78M |
| October 30, 2024 | 651.78M |
| October 29, 2024 | 636.50M |
| October 28, 2024 | 636.50M |
| October 25, 2024 | 686.85M |
| October 24, 2024 | 686.85M |
| October 23, 2024 | 686.85M |
| October 22, 2024 | 686.85M |
| October 21, 2024 | 641.18M |
| October 18, 2024 | 641.18M |
| October 17, 2024 | 641.18M |
| October 16, 2024 | 810.91M |
| October 15, 2024 | 810.91M |
| October 14, 2024 | 810.91M |
| October 11, 2024 | 810.91M |
| Date | Value |
|---|---|
| October 10, 2024 | 810.91M |
| October 09, 2024 | 810.91M |
| October 08, 2024 | 810.91M |
| October 07, 2024 | 810.91M |
| October 04, 2024 | 810.91M |
| October 03, 2024 | 810.91M |
| October 02, 2024 | 810.91M |
| October 01, 2024 | 810.91M |
| September 30, 2024 | 822.60M |
| September 27, 2024 | 822.60M |
| September 26, 2024 | 822.60M |
| September 25, 2024 | 822.60M |
| September 24, 2024 | 822.60M |
| September 23, 2024 | 822.60M |
| September 20, 2024 | 822.60M |
| September 19, 2024 | 822.60M |
| September 18, 2024 | 822.60M |
| September 17, 2024 | 738.99M |
| September 16, 2024 | 738.99M |
| September 13, 2024 | 738.99M |
| September 12, 2024 | 738.99M |
| September 11, 2024 | 738.99M |
| September 10, 2024 | 738.99M |
| September 09, 2024 | 738.99M |
| September 06, 2024 | 738.99M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
636.50M
Minimum
Oct 29 2024
1.866B
Maximum
May 25 2023
1.092B
Average
1.006B
Median
Mar 25 2020
Market Cap Benchmarks
| Takeda Pharmaceutical Co Ltd | 43.20B |
| PeptiDream Inc | 2.203B |
| Healios KK | 135.20M |
| AnGes Inc | 98.24M |
| SanBio Co Ltd | 264.23M |
Market Cap Related Metrics
| PS Ratio | 3.644 |
| Price to Book Value | 1.689 |
| Price to Free Cash Flow | 70.97 |
| Price | 8.052 |
| Earnings Yield | -3.39% |